Gilead, US FDA Ponder Innovative Designs For Descovy HIV Prevention Study In Women

 
• By Sue Sutter

Advisory committee sent a clear message that pre-exposure prophylaxis studies are needed in cisgender women, but what those studies might look like, and whether the agency can exercise its statutory authorities to ensure they are conducted, is less clear.

KORONADAL CITY, PHILIPPINES – JANUARY 28, 2017: Rubik's Cube was invented in 1974 by Hungarian sculptor and professor of architecture Erno Rubik. Hands of a young lady trying to solve the puzzle. - Image
Gilead and the FDA are trying to solve the problem of how to study Truvada's successor, Descovy, for PrEP in cisgender women. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers